en.Wedoany.com Reported - Evonik has signed an agreement with the ProChem Group to sell part of its active ingredient production facilities at the Hanau site. As a chemical and pharmaceutical contract manufacturer, ProChem took over these facilities in June.

For years, Evonik has produced active pharmaceutical ingredients, intermediates, and lipids for the pharmaceutical industry at the Wolfgang Industrial Park. In line with its growth strategy adjustments, Evonik plans to cease keto acid production in Hanau by the end of 2025.

Evonik will continue to operate its pharmaceutical lipid facility in Hanau, supplying clinical and small-scale commercial quantities to customers from this site.

ProChem is taking over Evonik's existing facilities, structures, and licenses, enabling the new site partner to quickly commence production at the Wolfgang Industrial Park. ProChem plans to expand its workforce at the park to approximately 30 people within this year.

"With the Hanau site, we have acquired state-of-the-art facilities, quality-assured processes, and excellent industrial infrastructure," said Dr. Jörg Blumhoff, Sales Director of the ProChem Group. "This allows us to significantly expand our service portfolio and offer our customers more comprehensive, scalable, and compliant solutions in the future."

Kerstin Oberhaus, Site Manager at Evonik, emphasized: "With ProChem's arrival, we have gained a strong industrial partner that will further develop the existing facilities, thereby strengthening the long-term competitiveness of the Wolfgang Industrial Park. We warmly welcome ProChem and look forward to collaboration."

The Hanau site significantly expands the ProChem Group's existing production network and opens up new opportunities for its customers in demanding and regulated markets. A key milestone is that, following the acquisition, the ProChem Group will be able to offer production under GMP conditions, thereby actively responding to the growing market demand for high-quality, compliant contract manufacturing.

This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com